Autres langues Alembic Pharmaceuticals Limited

Actions

APLLTD

INE901L01018

Produits pharmaceutiques

Marché Fermé - NSE India S.E. 14:23:44 25/09/2026			Varia. 5j.	Varia. 1 janv.
863,75 ^INR	+1,62%		+2,13%	+2,08%

20/08	Alembic Pharmaceuticals Limited annonce la nomination de Chirag Shukla au poste de secrétaire général et responsable de la conformité, à compter du 20 août 2026	CI
10/08	Alembic Pharmaceuticals Limited annonce la démission de Manisha Saraf de ses fonctions de secrétaire générale et responsable de la conformité, effective au 10 août 2026	CI

Autres langues

20/08	Alembic Pharmaceuticals Limited Announces Appointment of Chirag Shukla to Company Secretary & Compliance Officer, Effective August 20, 2026
10/08	Alembic Pharmaceuticals Limited Announces Resignation of Manisha Saraf as Company Secretary and Compliance Officer, Effective August 10, 2026
06/08	Alembic Pharmaceuticals Limited Appoints Mr. Sujit Jaysukh Bhayani as an Independent Director
04/08	Alembic Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
04/08	India's Alembic Pharma posts quarterly profit rise on strong generics demand
28/07	Alembic Pharmaceuticals Limited Receives USFDA Final Approval For Prucalopride Tablets, 1 Mg And 2 Mg
22/07	Alembic Pharmaceuticals Receives Warning Letter From Center for Drug Evaluation and Research
18/07	Alembic Pharmaceuticals Limited?s Partner Natco Pharma Limited Receives USFDA Tentative Approval For Olaparib Tablets, 100 Mg and 150 Mg
15/07	Alembic Therapeutics LLC Announces Exclusive U.S. Distribution Of NUVESSA (Metronidazole Vaginal Gel 1.3%)
11/07	Alembic Pharmaceuticals Limited announces Annual dividend, payable on September 04, 2026
26/06	Alembic Pharmaceuticals Limited Receives USFDA Final Approval For Oseltamivir Phosphate For Oral Suspension, 6 Mg/Ml
19/06	Alembic Pharmaceuticals Limited Receives USFDA Tentative Approval For Binimetinib Tablets, 45 Mg
12/06	Indian Equities Rally on Friday as US-Iran Deal Hopes, Easing Oil Prices Boost Sentiment
12/06	Alembic Pharma Gets Final NoD From USFDA for Tretinoin Cream
12/06	Alembic Pharmaceuticals Limited Receives USFDA Final Approval For Tretinoin Cream USP, 0.05%
11/06	Alembic Pharmaceuticals Gets USFDA Tentative Approval for Larotrectinib Capsules
11/06	Alembic Pharmaceuticals Limited Receives USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg
08/06	Alembic Pharmaceuticals to Acquire 45% Stake in Canadian Venture
06/06	17989377 Canada Inc. announced that it expects to receive funding from Alembic Pharmaceuticals Limited, DifGen Pharmaceuticals LLC and other investor
05/06	Alembic Pharmaceuticals Gets USFDA Approval for Haloperidol Tablets
05/06	Alembic Pharmaceuticals Limited Receives Usfda Final Approval for Haloperidol Tablets Usp 1 Mg 2 Mg 5 Mg 10 Mg and 20 Mg
03/06	Alembic Pharmaceuticals Limited Announces Appointment of Tushar Mehta as Head-R&D, Effective June 3, 2026
02/06	Alembic Pharmaceuticals Limited Announces That Atul Suri Senior Vice President - Sales & Marketing Ceased to Be Senior Management Personnel , Effective June 2, 2026
01/06	Alembic Pharmaceuticals Limited Announces Appointment of Ramesh Juneja as Senior Management Personnel, Effective June 1, 2026
22/05	Alembic Pharmaceuticals receives US FDA final approval for levothyroxine sodium tablets